Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

82.15 USD +1.41 (+1.75%)
Official Closing Price Updated: 5:01 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 538,573
Open 80.61
Bid (Size) 82.07 (1)
Ask (Size) 82.15 (7)
Prev. Close 80.74
Today's Range 80.61 - 83.45
52wk Range 19.51 - 86.75
Shares Outstanding 87,577,188
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 First Quarter Results
Arrowhead to release earnings and hold conference call on February 4 2021 
From Business Wire News Releases
NeuBase Therapeutics Announces Appointment of Curt Bradshaw, Ph.D. as Chief Scientific Officer
From GlobeNewswire News Releases

Performance

YTD
+9.78%
+9.78%
1 Month
+0.15%
+0.15%
3 Month
+64.04%
+64.04%
6 Month
+60.23%
+60.23%
1 Year
+72.62%
+72.62%

More News

Read More
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
From Business Wire News Releases
First Week of February 2021 Options Trading For Arrowhead Pharmaceuticals (ARWR)
Tags Stocks
From Market News Video
Arrowhead Pharmaceuticals to Participate in Upcoming Conferences
From Business Wire News Releases
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda
From Business Wire News Releases
Noteworthy ETF Outflows: XBI, ARCT, FATE, ARWR
Tags ETFs
From ETF Channel
Noteworthy Tuesday Option Activity: ARWR, SYNH, XEC
Tags Stocks
From Market News Video
Stocks That Hit 52-Week Highs On Thursday
Tags SCCO 52/Week Highs SAGE
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
Tags INTZ CERS EVH
From Benzinga
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
Tags NEO SWAV SMTI
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.